Insurers commit to upholding vaccine coverage standards
(By: Jakob Emerson for Becker’s Hospital Review) Health insurers say they will continue to provide coverage for recommended immunizations without
Read More
Part D/Prescription Drugs
Why it matters to review your Medicare plan now
The Medicare Open Enrollment Period for 2026 runs from October 15 to December 7, 2025. During this time, Medicare participants
Read More5 healthcare policies to watch this month
(By: Madeline Ashley, Erica Cerutti, Alan Condon, and Jakob Emerson for Becker’s Hospital Review) Congress is staring down a fast-approaching
Read MoreFDA moves to cut expert panel input on new drugs
(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is moving to scale back its long-standing use of expert panels
Read MorePressure mounts against HHS’ 340B pilot: 5 notes
(By: Alexandra Murphy for Becker’s Hospital Review) A group of House lawmakers is urging HHS to scrap or revise its
Read MoreHealth care costs are soaring. Blame insurers, drug companies — and your employer
(By Maria Aspan for NPR) The United States has the most expensive health care in the developed world. Now it’s
Read MoreCVS Caremark to pay Oklahoma $32M over alleged underpayments
(By: Elizabeth Casolo for Becker’s Hospital Review) CVS Caremark will pay $32.1 million to the state of Oklahoma after the pharmacy
Read MorePaying a higher share of Medicare premiums
In May 2025, 68.9 million Americans were enrolled in Medicare according to the Centers for Medicare and Medicaid Services (CMS).
Read MoreVA expands precision medicine through pharmacogenomics
(Source – news.va.gov) In recent years, VA has become a national leader in precision medicine, using pharmacogenomics (PGx) to personalize
Read MoreWegovy gains new approval: 3 GLP-1 updates
(By: Paige Twenter for Becker’s Hospital Review) Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1
Read More